"UAMS Research Team's Breakthrough: Promising Drug Uncovered to Prevent Alzheimer's"
A research team at the University of Arkansas for Medical Sciences has discovered a drug, CBA2, that could prevent Alzheimer's disease by targeting the ApoE4 protein, a main cause of the disease. The drug, developed after years of research, has the potential to reduce the risk of developing Alzheimer's for those with genetic predisposition. While still in preclinical stages, the team has secured a provisional patent and is working towards further testing and development with the support of a $2.35 million grant from the National Institutes of Health.